Qiagen, a listed multinational provider of sample and assay technologies for molecular diagnostics, has set the final terms of its US$500m 2.5% convertible bonds due 2031. The initial conversion price…
The Netherlands: Qiagen announces final terms on US$500m convertible bonds
…
…






